243 related items for PubMed ID: 20442650
1. Low-dose cyclosporine treatment in Chinese nephrotic patients with idiopathic membranous nephropathy: An uncontrolled study with prospective follow-up.
Li J, Zhang YM, Qu Z, Zhao MH, Liu G.
Am J Med Sci; 2010 Jun; 339(6):532-6. PubMed ID: 20442650
[Abstract] [Full Text] [Related]
2. Cyclosporin A treatment for idiopathic membranous nephropathy.
Yao X, Chen H, Wang Q, Tang Z, Hu W, Yin G, Liu Z, Li L.
Chin Med J (Engl); 2001 Dec; 114(12):1305-8. PubMed ID: 11793859
[Abstract] [Full Text] [Related]
3. Triple therapy with single daily dose of cyclosporine in Japanese patients with idiopathic membranous nephropathy.
Matsumoto H, Nagaoka Y, Okada T, Wada T, Gondo A, Esaki S, Hayashi A, Miyaoka Y, Nakao T.
Intern Med; 2011 Dec; 50(18):1905-10. PubMed ID: 21921367
[Abstract] [Full Text] [Related]
4. Cyclosporine treatment in idiopathic membranous nephropathy nephrotic syndrome in adults: a retrospective study spanning 15 years.
Tao JL, Liu LL, Wen YB, Gao RT, Li H, Li MX, Li XM, Li XW.
Chin Med J (Engl); 2011 Nov; 124(21):3490-4. PubMed ID: 22340164
[Abstract] [Full Text] [Related]
5. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[Abstract] [Full Text] [Related]
6. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial.
Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL, North America Nephrotic Syndrome Study Group.
Kidney Int; 2001 Apr; 59(4):1484-90. PubMed ID: 11260412
[Abstract] [Full Text] [Related]
7. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
Liang Q, Li H, Xie X, Qu F, Li X, Chen J.
Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
[Abstract] [Full Text] [Related]
8. Treatment of idiopathic membranous nephropathy with combination of low-dose tacrolimus and corticosteroids.
He L, Peng Y, Liu H, Liu Y, Yuan S, Liu F, Yang D, Liu H, Chen X, Shao J, Fu M.
J Nephrol; 2013 Nov; 26(3):564-71. PubMed ID: 22956434
[Abstract] [Full Text] [Related]
9. Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents.
Li C, Li H, Wen YB, Li JN, Lin WF, Cai JF, Duan L, Li Y, Li XM, Li XW.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug 20; 39(4):544-551. PubMed ID: 28877834
[Abstract] [Full Text] [Related]
10. Efficacy of mizoribine followed by low-dose prednisone in patients with idiopathic membranous nephropathy and nephrotic-range proteinuria.
Matsumoto Y, Shimada Y, Nojima Y, Moriki T.
Ren Fail; 2013 Aug 20; 35(7):936-41. PubMed ID: 23815417
[Abstract] [Full Text] [Related]
11. Administration of low-dose cyclosporine alone for the treatment of elderly patients with membranous nephropathy.
Li MX, Yu YW, Zhang ZY, Zhao HD, Xiao FL.
Genet Mol Res; 2015 Mar 30; 14(1):2665-73. PubMed ID: 25867415
[Abstract] [Full Text] [Related]
12. Cyclosporine A in treatment of membranous lupus nephropathy.
Hu W, Liu Z, Shen S, Li S, Yao X, Chen H, Li L.
Chin Med J (Engl); 2003 Dec 30; 116(12):1827-30. PubMed ID: 14687467
[Abstract] [Full Text] [Related]
13. [The clinical efficacy and safety of modified Ponticelli regimen for treatment of idiopathic membranous nephropathy].
Xia W, Pei H, Li S, Fu S, Tian L.
Zhonghua Nei Ke Za Zhi; 2016 Mar 30; 55(3):181-5. PubMed ID: 26926368
[Abstract] [Full Text] [Related]
14. Leflunomide plus oral prednisone in treatment of idiopathic membranous nephropathy: a retrospective clinical study of efficacy and safety.
Yang S, Xie L, Xue W, Yin A, Lu W.
Nephrology (Carlton); 2013 Sep 30; 18(9):615-22. PubMed ID: 23889815
[Abstract] [Full Text] [Related]
15. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
Li X, Tian J, Wu J, He Q, Li H, Han F, Li Q, Chen Y, Ni Q, Chen J.
Clin Ther; 2009 Apr 30; 31(4):741-50. PubMed ID: 19446147
[Abstract] [Full Text] [Related]
16. Improving long-term outcomes in idiopathic membranous nephropathy using a distinctive cyclosporine regimen.
Hassan K, Kristal B.
Minerva Urol Nefrol; 2016 Jun 30; 68(3):293-301. PubMed ID: 25645342
[Abstract] [Full Text] [Related]
17. Cyclosporine versus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: A 3-year prospective study.
Naumovic R, Jovanovic D, Pavlovic S, Stosovic M, Marinkovic J, Basta-Jovanovic G.
Biomed Pharmacother; 2011 Mar 30; 65(2):105-10. PubMed ID: 21109389
[Abstract] [Full Text] [Related]
18. The Effect of Mycophenolate Mofetil versus Cyclosporine as Combination Therapy with Low Dose Corticosteroids in High-risk Patients with Idiopathic Membranous Nephropathy: a Multicenter Randomized Trial.
Choi JY, Kim DK, Kim YW, Yoo TH, Lee JP, Chung HC, Cho KH, An WS, Lee DH, Jung HY, Cho JH, Kim CD, Kim YL, Park SH.
J Korean Med Sci; 2018 Feb 26; 33(9):e74. PubMed ID: 29441742
[Abstract] [Full Text] [Related]
19. Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: a multicenter randomized controlled trial.
Chen M, Li H, Li XY, Lu FM, Ni ZH, Xu FF, Li XW, Chen JH, Wang HY, Chinese Nephropathy Membranous Study Group.
Am J Med Sci; 2010 Mar 26; 339(3):233-8. PubMed ID: 20220333
[Abstract] [Full Text] [Related]
20. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
Am J Kidney Dis; 2009 May 26; 53(5):760-9. PubMed ID: 19268410
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
